DI
Diaceutics PLC
DIUXF · OTC
$2.00 +0.00% (+$0.00)
Market Cap £126.7M
P/E Ratio 1,306.68x
Div. Yield -
ROE 0.25%
Bulios Fair Price
$1.64
18.0% downside
Current Price
$2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DIUXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
18 /100
Expensive P/FCF 88.94x
P/S 3.30x
P/B 3.13x
Growth
62 /100
Stable Rev. growth 25.37%
FCF growth 72.41%
Book val. growth 1.63%
Profitability
30 /100
Weak Net margin 0.25%
Op. margin 0.55%
FCF margin 3.71%
Quality
11 /100
Poor ROE 0.25%
ROA 0.19%
Asset turnover 0.77x
Debt
80 /100
Low Current ratio 3.43x
Int. coverage -3.66x
Net debt/EBITDA -1.11x
Stability
57 /100
Moderate Rev. volatility 8.82%
EPS volatility 236.82%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DIUXF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ryan Keeling
Employees
205
Headquarters
Belfast
Upcoming events
22 SEP
Earnings
Upcoming earnings report